filter by tag
Answers tagged JAK: Page 1 of 1
Mona from Calgary asks: I don’t see anything about Rinvoq. My rheumatologist has suggested that one for me.
Rinvoq, otherwise known as Upadacitinib, is part of a newer class of advanced disease modifying medications for inflammatory arthritis called JAK Kinase inhibitors. To learn more about it and the other JAK Kinase inhibitors that are currently available, visit our webpage here.
Richard form Montreal asks: Is Xeljanz (tofacitinib) covered in Alberta?
Every province has slightly different rules for coverage of advanced therapies such as tofacinitib, and biologics. That said, in most situations, working with your current rheumatologist, or your new rheumatologist if you are planning a move to Alberta, a solution is found to ensure you can continue to receive the treatment that makes you well.